FDA panel meets to consider booster shots

By The New York Times
| September 17, 2021

The meeting comes as debate intensifies over whether additional shots are needed now, and for whom. A virus surge in the U.S. seems to be showing signs of slowing, though new deaths remain high.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...